Prosecution Insights
Last updated: October 04, 2026

SAMYANG Corporation

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Analysis

SAMYANG Corporation currently has 9 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 9 distinct examiners and 7 distinct art units. SUBBALAKSHMI PRAKASH is the busiest examiner for the corporation, currently managing 1 pending office action.

The presence of the pending office actions in Biotechnology & Pharmaceuticals indicates a significant and active interest in this field. The distribution across distinct examiners means that every pending matter is being reviewed by a different individual, providing a wide range of examiner perspectives. Furthermore, the involvement of 7 distinct art units suggests that the corporation's filings are technically diverse, spanning multiple specialized areas within biotechnology and pharmaceuticals.

With SUBBALAKSHMI PRAKASH handling 1 pending office action, the workload is perfectly distributed among the examiners. This lack of concentration means that no single examiner's decisions will disproportionately affect the entire portfolio. Practitioners must navigate the distinct art units, each with its own nuances, while managing separate examiner relationships. This decentralized prosecution profile requires a broad strategy to address the various requirements of the 9 distinct examiners involved.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (30%)
5
Medium (50%)
2
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (30%)
§102 only1 (10%)
§112 only2 (20%)
Double-patenting + other1 (10%)
Multi-statute (no §101)3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PRAKASH, SUBBALAKSHMI 1 45.7% +36.1%
BERRY, LAYLA D 1 66.0% +9.0%
REGLAS, GEORGIANA C 1 37.7% +36.1%
GRASER, JENNIFER E 1 76.7% +23.4%
CHO, DAVID H 1 31.9% +67.0%
LACHICA, ERICSON M 1 30.0% +35.4%
NOAKES, SUZANNE MARIE 1 73.3% +18.2%
BHUSHAN, KUMAR R 1 73.4% +32.8%
KOLB, KATARZYNA I 1 45.2% +15.9%
LEBLANC, KATHERINE DEGUIRE 1 34.6% +35.8%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18765473 METHOD FOR PRODUCING FUNCTIONAL CRYSTALLINE SWEETENER BERRY, LAYLA D —
18267553 ALLULOSE WITH IMPROVED STABILITY LACHICA, ERICSON M —
18265998 YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR NOAKES, SUZANNE MARIE —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18267867 DEXTRIN WITH IMPROVED TURBIDITY, AND METHOD FOR PRODUCING SAME CHO, DAVID H 30d overdue
17909196 POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION HAVING EXCELLENT FLAME RETARDANCY AND HYDROLYSIS RESISTANCE AND MOLDED ARTICLE PRODUCED THEREFROM KOLB, KATARZYNA I 16d
18270293 RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME GRASER, JENNIFER E 56d
18868910 ALLULOSE COMPOSITION WITH EXCELLENT STABILITY PRAKASH, SUBBALAKSHMI —
18722755 GLYCOSYLTRANSFERASE VARIANT, AND METHOD OF PREPARING STEVIOL GLYCOSIDES USING SAME REGLAS, GEORGIANA C —
18267553 ALLULOSE WITH IMPROVED STABILITY LACHICA, ERICSON M —
18265998 YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR NOAKES, SUZANNE MARIE —
18014938 ALKYLENE-OXIDE-ADDED POLYOL COMPOSITION, POLYURETHANE USING SAME, AND HOT-MELT ADHESIVE COMPRISING SAME BHUSHAN, KUMAR R —

Top Art Units

Art UnitApps
1651 1
1645 1
1693 1
1792 1
1656 1
1766 1
1767 1
1791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18868910 ALLULOSE COMPOSITION WITH EXCELLENT STABILITY PRAKASH, SUBBALAKSHMI — §103 Non-Final OA — Pending Nov 25, 2024
18765473 METHOD FOR PRODUCING FUNCTIONAL CRYSTALLINE SWEETENER BERRY, LAYLA D — §102§112 Non-Final OA — Pending Jul 08, 2024
18722755 GLYCOSYLTRANSFERASE VARIANT, AND METHOD OF PREPARING STEVIOL GLYCOSIDES USING SAME REGLAS, GEORGIANA C 1651 §112DP Non-Final OA — Pending Jun 21, 2024
18270293 RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME GRASER, JENNIFER E 1645 §112 Final Rejection 56d Pending Jun 29, 2023
18267867 DEXTRIN WITH IMPROVED TURBIDITY, AND METHOD FOR PRODUCING SAME CHO, DAVID H 1693 §112 Final Rejection 30d overdue Pending Jun 16, 2023
18267553 ALLULOSE WITH IMPROVED STABILITY LACHICA, ERICSON M 1792 §103§112 Non-Final OA — Pending Jun 15, 2023
18265998 YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR NOAKES, SUZANNE MARIE 1656 §102§103§112 Final Rejection — Pending Jun 08, 2023
18014938 ALKYLENE-OXIDE-ADDED POLYOL COMPOSITION, POLYURETHANE USING SAME, AND HOT-MELT ADHESIVE COMPRISING SAME BHUSHAN, KUMAR R 1766 §102Other Non-Final OA — Pending Jan 06, 2023
17909196 POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION HAVING EXCELLENT FLAME RETARDANCY AND HYDROLYSIS RESISTANCE AND MOLDED ARTICLE PRODUCED THEREFROM KOLB, KATARZYNA I 1767 §103 Non-Final OA 16d Pending Sep 02, 2022
17255008 SWEETENER POWDER COMPOSITION AND PREPARATION METHOD THEREFOR LEBLANC, KATHERINE DEGUIRE 1791 §103 Non-Final OA — Pending Dec 22, 2020

Managing SAMYANG Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month